Mycobacterial Programs
UT Tyler's leadership in mycobacterial diseases is grounded in a history that spans more than seven decades.
The UT Tyler Health Science Center was originally established in the post-World War II era as a tuberculosis (TB) sanatorium. The institution later became the East Texas Tuberculosis Hospital—one of the region’s most prominent centers for TB care. As therapies advanced and the epidemiology of TB shifted, the hospital evolved into a modern health science center and ultimately into The University of Texas at Tyler School of Medicine.
This rich history in TB care laid the foundation for UT Tyler’s continued national leadership in mycobacterial diseases. Through a longstanding charter, UT Tyler maintains historic and operational connections not just in East Texas, but across the state.
Complementing these clinical and diagnostic strengths, UT Tyler also participates in several ongoing clinical trials focused on NTM and related pulmonary diseases. These research efforts—supported by federal, state and industry partnerships—have helped to advance innovations in TB, NTM, antimicrobial resistance and clinical diagnostics.
Together, these interconnected enterprises form one of the most robust and comprehensive mycobacterial programs in the nation, rooted in historic expertise and driven by a mission to improve patient outcomes and advance the science of mycobacterial diseases.
